A Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Adding ETC-1002 180 mg to Atorvastatin 80 mg Background Therapy in Statin-Treated Patients.
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Bempedoic acid (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Esperion Therapeutics
- 16 Nov 2016 Status changed from active, no longer recruiting to completed.
- 03 May 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Jan 2016 Status changed from planning to recruiting as reported by ClinicalTrials.gov.